Primary Record
Inecalcitol
- In stock
- 5,966 g
- Purity
- 99.7 %
- CAS
- 163217-09-2
Compound Identifiers & Properties
- CAS
- 163217-09-2
- PubChem CID
- 6915835
- SMILES
- C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C
- Canonical SMILES
- C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C
Names & Synonyms
- Inecalcitol
- Inecalcitol [INN]
- Inecalcitol oral
- TX-522
- TX527 cpd
- 163217-09-2
- INECALCITOLUM
- AC1OCD0K
- RefChem:148255
- TX 522
- UNII-05FZV98342
- D00CPS
- D0R8IE
- TX-527
- Vitamin D analogs, KULeuven
- SCHEMBL754593
- DTXSID60870084
- GTPL7747
- orb1305513
- 05FZV98342
- CHEMBL2105107
- TX 527
- DTXCID001511070
- GLXC-05014
- TX522
- C26H40O3
- EX-A5555
- 8151AH
- LMST03020649
- ZINC12504514
- AKOS025312295
- AN-7569
- CID6915835
- DB04796
- 19-Nor-14-epi-23-yne-1,25 dihydroxyvitamin D3
- CID:6915835
- HY-32344
- Inecalcitol (sc, psoriasis), Hybrigenics
- MS-26815
- SID:134222765
- (1R,3R)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylhept-4-yn-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
- CS-0001525
- NS00070816
- J1.322.262B
- G13594
- Vitamin D analog (sc, psoriasis), Hybrigenics
- Inecalcitol (oral, hyperthyroidism), Hybrigenics
- Vitamin D analogs, Catholic University of Leuven
- A936500
- C409043
- Q27078058
- (7E)-19-Nor-9,10-seco-14beta-cholesta-5,7-dien-23-yne-1alpha,3beta,25-triol
- B2693-453195
- Inecalcitol (oral, prostate cancer/psoriasis), Hybrigenics
- (7E)-(1R,3R,14R)-19-nor-23-yne-9,10-seco-5,7-cholestadiene-1,3,25-triol
- (7E)-19-nor-9,10-seco-14bet-cholesta-5,7-dien-23-yne-, 1alpha, 3beta, 25-triol
- 19-NOR-14-EPI-23-YNE-1,25 DIHYDROXYVITAMIN D3, TX522
- 9,10-seco-14bh-19-norcholesta-5(z),7(e)-dien-1(r),3(r),25-triol-23-yne
- (1R,3R)-5-((2E)-2-((1R,3aR,7aR)-1-((2R)-6-hydroxy-6-methylhept-4-yn-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
- (1R,3R)-5-((E)-2-((1R,3AR,7aR)-1-((R)-6-Hydroxy-6-methylhept-4-yn-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)cyclohexane-1,3-diol
- (1R,3R)-5-(2-((1R,3aR,7aR,E)-1-((R)-6-hydroxy-6-methylhept-4-yn-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
- (1R,3R)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(1R)-5-hydroxy-1,5-dimethyl-hex-3-ynyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
- (1R,3R)-5-{2-[(1R,3aR,4E,7aR)-1-[(2R)-6-hydroxy-6-methylhept-4-yn-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}cyclohexane-1,3-diol
- (1R,3R,7E)-17beta-[(2R)-6-Hydroxy-6-methylhept-4-yn-2-yl]-14beta-9,10-secoestra-5,7-diene-1,3-diol
- (3abeta)-Octahydro-1beta-[(1R)-1,5-dimethyl-5-hydroxy-3-hexynyl]-7abeta-methyl-4-[(1E)-2-(3beta,5alpha-dihydroxycyclohexane-1-ylidene)ethylidene]-1H-indene
- (7E)-19-NOR-9,10-SECO-14.BETA.-CHOLESTA-5,7-DIEN-23-YNE-1.ALPHA.,3.BETA.,25-TRIOL
- 1,3-CYCLOHEXANEDIOL, 5-((2E)-2-((1R,3AR,7AR)-OCTAHYDRO-1-((1R)-5-HYDROXY-1,5-DIMETHYL-3-HEXYN-1-YL)-7A-METHYL-4H-INDEN-4-YLIDENE)ETHYLIDENE)-, (1R,3R)-